Axel Bolte - 31 Mar 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Axel Bolte
Issuer symbol
INZY
Transactions as of
31 Mar 2023
Net transactions value
+$10,621
Form type
4
Filing time
04 Apr 2023, 08:40:03 UTC
Previous filing
04 Oct 2022
Next filing
03 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $10,621 +4,806 +1.8% $2.21 266,696 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2022 through March 31, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on October 3, 2022, the first trading day of the purchase period.